Biomea Fusion, Inc. - Common Stock (BMEA)
2.9100
0.00 (0.00%)
Biomea Fusion Inc is a biotechnology company focused on the development of targeted therapies for cancer treatment
The company leverages its proprietary drug discovery platform to identify and create innovative small molecule therapeutics aimed at addressing specific genetic mutations that drive tumor growth. By utilizing advanced technology and scientific expertise, Biomea Fusion actively works to improve patient outcomes through precision medicine, aiming to provide more effective and personalized treatment options for individuals battling various forms of cancer.
Frequently Asked Questions
Is Biomea Fusion, Inc. - Common Stock publicly traded?
Yes, Biomea Fusion, Inc. - Common Stock is publicly traded.
What exchange does Biomea Fusion, Inc. - Common Stock trade on?
Biomea Fusion, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Biomea Fusion, Inc. - Common Stock?
The ticker symbol for Biomea Fusion, Inc. - Common Stock is BMEA on the Nasdaq Stock Market
What is the current price of Biomea Fusion, Inc. - Common Stock?
The current price of Biomea Fusion, Inc. - Common Stock is 2.910
When was Biomea Fusion, Inc. - Common Stock last traded?
The last trade of Biomea Fusion, Inc. - Common Stock was at 4:00 pm EST on March 5th, 2025